Superworth

Janux Therapeutics EPS JANX

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Last 12 months, to Jun 30, 2026
−$1.64
Latest quarter, Q2 FY26
−$0.35
Fiscal year 2025
−$1.83

Janux Therapeutics' earnings per share was −$1.64 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.35.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.83n/a
FY2024−$1.28n/a
FY2023−$1.34n/a
FY2022−$1.52n/a
FY2021−$3.27n/a
FY2020−$7.46n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.35n/a−$1.64
Q1 FY26−$0.39n/a−$1.84
Q4 FY25−$0.51n/a−$1.83
Q3 FY25−$0.39n/a−$1.68
Q2 FY25−$0.55n/a−$1.80
Q1 FY25−$0.38n/a−$1.36
Q4 FY24−$0.36n/a−$1.28
Q3 FY24−$0.51n/a−$1.17
Q2 FY24−$0.11n/a−$0.91
Q1 FY24−$0.30n/a−$1.22
Q4 FY23−$0.25n/a−$1.34
Q3 FY23−$0.25n/a−$1.48

Against its peers

Companies in Drug Manufacturers - General nearest Janux Therapeutics' size, closest first, today.

CompanyEPS, 12 monthsGrowth
JANXJanux Therapeutics−$1.64
AMPHAmphastar Pharmaceuticals$1.70−36% a year
OMEROmeros$1.52
ABUSArbutus Biopharma$0.78
COLLCollegium Pharmaceutical$1.24+19% a year
PCRXPacira BioSciences$0.35
ANABAnaptysbio$4.57
PAHCPhibro Animal Health$2.44+107% a year
ANIPANI Pharmaceuticals$4.70
CRMDCorMedix$2.13+184% a year
ZVRAZevra Therapeutics$0.93
Peer median$1.61

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Janux Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.